HomeGYRE • NASDAQ
add
Gyre Therapeutics Inc
Previous close
$17.11
Day range
$16.11 - $17.11
Year range
$5.88 - $30.40
Market cap
1.40B USD
Avg Volume
70.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 29.98M | 5.28% |
Operating expense | 26.47M | -7.14% |
Net income | -52.19M | -1,399.95% |
Net profit margin | -174.08 | -1,324.55% |
Earnings per share | — | — |
EBITDA | 2.45M | 312.69% |
Effective tax rate | -4.77% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 33.51M | 33.10% |
Total assets | 116.54M | 37.50% |
Total liabilities | 38.06M | 203.65% |
Total equity | 78.47M | — |
Shares outstanding | 85.42M | — |
Price to book | -81.48 | — |
Return on assets | 4.86% | — |
Return on capital | 7.18% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -52.19M | -1,399.95% |
Cash from operations | 4.03M | 685.57% |
Cash from investing | -776.15K | 32.94% |
Cash from financing | 1.38M | 1,072.31% |
Net change in cash | 4.49M | 267.89% |
Free cash flow | 4.09M | -21.67% |
About
Founded
2002
Headquarters
Website
Employees
593